SEC Filing Details

Document Details

Form
Filing Date
Dec 4, 2018
Document Date
Dec 3, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.
Filer
McMahon Gerald PhD

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline